Hansa Biopharma AB (publ) announced that Ulf Wiinberg is not standing for re-election as director at its Annual General Meeting to be held on June 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.32 SEK | +0.44% | -6.76% | +4.27% |
Apr. 18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
Apr. 18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.27% | 137M | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- HNSA Stock
- News Hansa Biopharma AB
- Hansa Biopharma AB Announces Ulf Wiinberg Not to Stand for Re-Election as Director